Cadrenal Therapeutics, Inc (CVKD) insider trading
Every open-market stock purchase and sale by Cadrenal Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $542K over the last 12 months (13 sales). No open-market buys.
- Last insider buy: John Raymond Murphy (Director), $1.8K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $542K (13 sales). Last close $0.97 on Oct 22, 2026.
Recent CVKD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 9, 2026 | Quang X Pham (CEO) | Bought (not open market) | — |
| Oct 9, 2026 | Lee Scott Golden (Director) | Bought (not open market) | — |
| Oct 9, 2026 | John Raymond Murphy (Director) | Bought (not open market) | — |
| Oct 9, 2026 | Jeffrey Scott Cole (COO) | Bought (not open market) | — |
| Oct 9, 2026 | Glynn Wilson (Director) | Bought (not open market) | — |
| Jun 29, 2026 | Quang X Pham (CEO) | Sold | $22.4K |
| Jun 26, 2026 | Quang X Pham (CEO) | Sold | $27.5K |
| Jun 25, 2026 | Quang X Pham (CEO) | Sold | $6.4K |
| Jun 23, 2026 | Quang X Pham (CEO) | Sold | $7.3K |
| Jun 22, 2026 | Quang X Pham (CEO) | Sold | $32.5K |
| Jun 17, 2026 | Quang X Pham (CEO) | Sold | $1.6K |
| Jun 16, 2026 | Quang X Pham (CEO) | Sold | $11.5K |
| Jun 15, 2026 | Quang X Pham (CEO) | Sold | $13.1K |
| Jun 12, 2026 | Quang X Pham (CEO) | Sold | $51.2K |
| Jun 11, 2026 | Quang X Pham (CEO) | Sold | $6K |
| Jun 10, 2026 | Quang X Pham (CEO) | Sold | $14.7K |
| Jun 9, 2026 | Quang X Pham (CEO) | Sold | $52.7K |
| Jun 8, 2026 | Quang X Pham (CEO) | Sold | $25.8K |
| Jun 5, 2026 | Quang X Pham (CEO) | Sold | $9.1K |
| Jun 4, 2026 | Quang X Pham (CEO) | Sold | $17.2K |
| Jun 3, 2026 | Quang X Pham (CEO) | Sold | $9.9K |
| Jun 2, 2026 | Quang X Pham (CEO) | Sold | $1.6K |
| May 29, 2026 | Quang X Pham (CEO) | Sold | $1.5K |
| May 28, 2026 | Quang X Pham (CEO) | Sold | $14.7K |
| May 22, 2026 | Quang X Pham (CEO) | Sold | $6.6K |
Who's trading CVKD
- Jeffrey Scott Cole, COO: other filings, last Oct 9, 2026
- Lee Scott Golden, Director: other filings, last Oct 9, 2026
- John Raymond Murphy, Director: other filings, last Oct 9, 2026
- Quang X Pham, CEO: sold $423K (24 sales), last Oct 9, 2026
- Glynn Wilson, Director: other filings, last Oct 9, 2026
- Matthew K Szot, CFO: sold $120K (3 sales), last Dec 29, 2025
Get free alerts when an insider at Cadrenal Therapeutics, Inc files a new trade →